Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 9 member 3 pseudogene 2 (SLC9A3P2)
- Target
- SLC9A3P2
- Molecular classification
- Other (Pseudogene; not an enzyme, transporter, receptor, or structural protein)
01
Overview
SLC9A3P2 is a pseudogene located in the human genome and is related to the solute carrier family 9 member 3 (SLC9A3), which encodes the sodium/hydrogen exchanger 3 (NHE3), a membrane protein central to sodium and acid-base homeostasis[4]. Pseudogenes like SLC9A3P2 do not encode functional proteins, lack established biological activity, and are generally not considered clinical or pharmacological targets[5]. Instead, the functional gene, SLC9A3, is crucial in sodium absorption in the kidney and intestine, but SLC9A3P2 does not participate in these physiological processes[4][2].
- Other names
- Solute carrier family 9 (sodium/hydrogen exchanger), member 3 pseudogene 2SLC9A3P2Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 pseudogene 2SLC9A3 pseudogene 2
02
Mechanism of action
None (No drugs or mechanism of action as this is a non-functional sequence)
03
Biological functions
Other (Does not have known biological function as it is a pseudogene)
04
Disease associations
Other (No direct disease role or association; SLC9A3 gene mutations—not the pseudogene—are linked to certain disorders)
05
Safety considerations
None (No safety concerns reported)
06
Interacting drugs
None (No drugs known to target this pseudogene)
07
Biomarkers
None (Not used as a biomarker)
Beyond the preview
Go deeper on Solute carrier family 9 member 3 pseudogene 2 (SLC9A3P2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Solute carrier family 9 member 3 pseudogene 2 (SLC9A3P2).